In the case of grade 4 hypertension (ie, hypertension with life-threatening consequences), the MEK inhibitor should be permanently discontinued, BRAF inhibitor should be temporarily stopped and hypertension treated on an urgent basis.10 This evidence concerns the gene MAP2K7 and Hypertension.